HSCT FOR CHRONIC MYELOPROLIFERATIVE DISEASES
Primary myelofibrosis, polycythemia vera, essential thrombocythemia
DOI:
https://doi.org/10.46765/2675-374X.2021v4n1p89-100Abstract
THE BRAZILIAN SOCIETY FOR BLOOD AND MARROW TRANSPLANTATION (SBTMO) PRESENTS THE BRAZILIAN GUIDELINES ON HEMATOPOIETIC STEM CELL TRANSPLANTATION
Downloads
Published
03/11/2021
How to Cite
Funke, V. A. M., Colella, M. P., Macedo, A. V. de, Teixeira, G. M., Ribeiro, A. A. F., & Vigorito, A. C. (2021). HSCT FOR CHRONIC MYELOPROLIFERATIVE DISEASES: Primary myelofibrosis, polycythemia vera, essential thrombocythemia. JOURNAL OF BONE MARROW TRANSPLANTATION AND CELLULAR THERAPY, 2(1), 89–100. https://doi.org/10.46765/2675-374X.2021v4n1p89-100
Issue
Section
Original article